Abstract
The epidemiology of fungal diseases changed, and molds have been increasingly associated with high mortality in severe immunocompromised patients. Invasive mold diseases may originate from the airborne conidia through inhalation or inoculation in skin fissures associated with indwelling catheters, wounds, burns, or onychomycosis. The diagnosis and treatment of fungal diseases is problematic and raises considerable challenges. Diagnosis of invasive mold diseases includes several methodologies, of which the most commonly used are the cultural methods, antigen testing, nucleic acid detection, and radiological imaging. Galactomannan and (1 → 3)-β-d-glucan detection significantly improved mold diagnosis in the last decade. Several molecular strategies have been proposed over the years but no consensus was achieved for standardized protocols or cut-off values. Recently, the first commercially available molecular assay for detection of Aspergillus was tested and the results were highly reproducible. In addition, blood cultures may also be helpful for invasive aspergillosis by following a novel procedure for the recovery of Aspergillus spp. from blood cultures. The association of distinct diagnostic methods, particularly molecular tests, galactomannan, and/or (1 → 3)-β-d-glucan detection, may provide earlier and more sensitive diagnosis of mold diseases and be indicative for early antifungal treatment. Accurate routine use of diagnostic tests can be cost-effective for laboratories and be of great value to patients.
Similar content being viewed by others
References
McNeil MM, Nash SL, Hajjeh RA, Phelan MA, Conn LA, Plikaytis BD, Warnock DW (2001) Trends in mortality due to invasive mycotic diseases in the United States, 1980–1997. Clin Infect Dis 33:641–647
Araujo R, Carneiro A, Costa-Oliveira S, Pina-Vaz C, Rodrigues AG, Guimaraes JE (2008) Fungal infections after haematology unit renovation: evidence of clinical, environmental and economical impact. Eur J Haematol 80:436–443
Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I (2009) Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47:129–133
Wirk B, Wingard JR (2009) Current approaches in antifungal prophylaxis in high risk hematologic malignancy and hematopoietic stem cell transplant patients. Mycopathologia 168:299–311
Gavaldà J, Román A (2007) Infection in lung transplantation. Enferm Infecc Microbiol Clin 25:639–649
Patterson JE (1999) Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1:229–236
de Pablo A, Ussetti P, Cruz Carreño M, Lázaro T, Ferreiro MJ, López A, Mendaza P, Estada J (2000) Aspergillosis in pulmonary transplantation. Enferm Infecc Microbiol Clin 18:209–214
García-Ruiz JC, Amutio E, Pontón J (2004) Invasive fungal infection in immunocompromised patients. Rev Iberoam Micol 21:55–62
Lacombe C, Lewin M, Monnier-Cholley L, Pacanowiski J, Poirot JL, Arrivé L, Tubiana JM (2007) Imaging of thoracic pathology in patients with AIDS. J Radiol 88:1145–1154
Guazzelli LS, Unis G, Xavier MO, Severo CB, Picon PD, Severo LC (2009) Fungus ball in HIV-infected patients. Rev Inst Med Trop Sao Paulo 51:345–348
Chande C, Menon S, Gohil A, Lilani S, Bade J, Mohammad S, Joshi A (2010) Cutaneous histoplasmosis in AIDS. Indian J Med Microbiol 28:404–406
Almyroudis NG, Kontoyiannis DP, Sepkowitz KA, DePauw BE, Walsh TJ, Segal BH (2006) Issues related to the design and interpretation of clinical trials of salvage therapy for invasive mold infection. Clin Infect Dis 43:1449–1455
Nucci M, Anaissie E (2009) Infections in patients with multiple myeloma. Semin Hematol 46:277–288
Vagace JM, Sanz-Rodriguez C, Casado MS, Alonso N, Garcia-Dominguez M, de la Llna FG, Zarallo L, Fajardo M, Bajo R (2007) Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report. BMC Infect Dis 7:40
Araujo R, Rodrigues AG (2004) Variability of germinative potential among pathogenic species of Aspergillus. J Clin Microbiol 42:4335–4337
Harun A, Blyth CC, Gilgado F, Middleton P, Chen SC, Meyer W (2011) Development and validation of a multiplex PCR for detection of Scedosporium spp. in respiratory tract specimens with cystic fibrosis. J Clin Microbiol 49:1508–1512
Cortez KJ, Roilides E, Quiroz-Telles F, Meletiadis J, Antachopoulos C, Knudsen T, Buchanan W, Milanovich J, Sutton DA, Fothergill A, Rinaldi MG, Shea YR, Zaoutis T, Kottilil S, Walsh TJ (2008) Infections caused by Scedosporium spp. Clin Microbiol Rev 21:157–197
Gomes MZ, Lewis RE, Kontoyannis DP (2011) Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species. Clin Microbiol Rev 24:411–445
Csomor J, Nikolova R, Sinkó J, Reményi P, Szabó Z (2004) Mucormycosis. Orv Hetil 145:2507–2513
Kara IO, Tasova Y, Uguz A, Sahin B (2009) Mucormycosis-associated fungal infections in patients with haematologic malignancies. Int J Clin Pract 63:134–139
Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG (2010) Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis 50:1091–1100
Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyannis DP (2006) Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989–2003). Haematologica 91:986–989
Pontón J (2002) Microbiological diagnosis of mycoses. Rev Iberoam Micol 19:25–29
Quindós G (2011) Candidiasis, aspergillosis and other invasive mycoses in recipients of solid organ transplants. Rev Iberoam Micol 28:110–119
Mayayo Artal E (2004) Histopathological diagnosis of mycoses. Rev Iberoam Micol 21:1–9
Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T (2006) Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 19:95–110
Huang YT, Hung CC, Liao CH, Sun HY, Chang SC, Chen YC (2007) Detection of circulating galactomannan in serum samples for diagnosis of Penicillium marneffei infection and cryptococcosis among patients infected with human immunodeficiency virus. J Clin Microbiol 45:2858–2862
Klingspor L, Loeffler J (2009) Aspergillus PCR formidable challenges and progress. Med Mycol 47:S241–S247
Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20:695–704
Rosa C, Araujo R, Rodrigues AG, Pinto-de-Sousa MI, Pina-Vaz C (2011) Detection of Aspergillus species in BACTEC blood cultures. J Med Microbiol 60:1467–1471
Ju MK, Joo DJ, Kim SJ, Chang HK, Kim MS, Kim SI, Kim YS (2009) Invasive pulmonary aspergillosis after solid organ transplantation: diagnosis and treatment based on 28 years of transplantation experience. Transplant Proc 41:375–378
Godet C, Elsendoorn A, Roblot F (2012) Benefit of CT scanning for assessing pulmonary disease in the immunodepressed patient. Diagn Interv Imaging 93:425–430
del Palacio A, Alhambra A, Cuétara MS, Pontón J (2007) Early diagnosis of invasive fungal infections caused by Aspergillus and other emerging mycelial fungi. Rev Iberoam Micol 24:187–197
Thornton CR (2010) Detection of invasive aspergillosis. Adv Appl Microbiol 70:187–216
Rovira M, Jimenéz M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M, Almela M, Martínez C, Fernández-Avilés F, Martínez JA, Urbano-Ispizua A, Carreras E, Montserrat E (2004) Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study. Transplantation 77:1260–1264
Guinea J, Jensen J, Peláez T, Gijón P, Alonso R, Rivera M, Muñoz P, Bouza E (2008) Value of a single galactomannan determination (Platelia) for the diagnosis of invasive aspergillosis in non-hematological patients with clinical isolation of Aspergillus spp. Med Mycol 46:575–579
Fortún J, Martín-Dávila P, Alvarez ME, Norman F, Sánchez-Sousa A, Gajate L, Bárcena R, Nuño SJ, Moreno S (2009) False-positive results of Aspergillus galactomannan antigenemia in liver transplant recipients. Transplantation 87:256–260
Kauffman CA (2008) Diagnosis of histoplasmosis in immunosuppressed patients. Curr Opin Infect Dis 21:421–425
Mori Y, Nagasaki Y, Kamezaki K, Takenaka K, Iwasaki H, Harada N, Miyamoto T, Abe Y, Shimono N, Akashi K, Teshima T (2010) High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol 85:449–451
Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J (2007) Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1– > 3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis 26:755–766
Alhambra A, Cuétara MS, Ortiz MC, Moreno JM, del Palacio A, Pontón J, del Palacio A (2007) False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Rev Iberoam Micol 24:106–112
Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL (2005) Evaluation of a (1- > 3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957–5962
Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A (2008) Contribution of the (1→3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 46:1009–1013
Burco JD, Ziccardi MH, Clemons KV, Tell LA (2012) Evaluation of plasma (1– > 3) beta-D-glucan concentrations in birds naturally and experimentally infected with Aspergillus fumigatus. Avian Dis 56:183–191
Rácil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J (2010) Difficulties in using 1,3-{beta}-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies – high frequency of false-positive results and their analysis. J Med Microbiol 59:1016–1022
Ostrosky-Zeichner L (2012) Invasive mycoses: diagnostic challenges. Am J Med 125:S14–S24
Singh N, Paterson DL (2005) Aspergillus infections in transplant recipients. Clin Microbiol Rev 18:44–69
Badiee P, Kordbacheh P, Alborzi A, Ramzi M, Shakiba E (2008) Molecular detection of invasive aspergillosis in hematologic malignancies. Infection 36:580–584
Luong ML, Filion C, Labbé AC, Roy J, Pépin J, Cadrin-Tourigny J, Carignan S, Sheppard DC, Laverdière M (2010) Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis 68:132–139
Kami M, Fukui T, Ogawa S, Kazuyama Y, Machida U, Tanaka Y, Kanda Y, Kashima T, Yamazaki Y, Hamaki T, Mori S, Akiyama H, Mutou Y, Sakamaki H, Osumi K, Kimura S, Hirai H (2001) Use of real-time PCR on blood samples for diagnosis of invasive aspergillosis. Clin Infect Dis 33:1504–1512
Kawazu M, Kanda Y, Goyama S, Takeshita M, Nannya Y, Niino M, Komeno Y, Nakamoto T, Kurokawa M, Tsujino S, Ogawa K, Aoki K, Chiba S, Motokura T, Ohish N, Hirai H (2003) Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid. Am J Hematol 72:27–30
del Palacio A, Cuétara MS, Pontón J (2003) Invasive aspergillosis. Rev Iberoam Micol 20:77–78
Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B (2007) Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 45:906–914
Deshpande P, Shetty A, Mehta A, Kapadia F, Hedge A, Soman R, Rodrigues C (2011) Standardization of fungal polymerase chain reaction for the early diagnosis of invasive fungal infection. Indian J Med Microbiol 29:406–410
Chen SC, Kontoyiannis DP (2010) New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients. Curr Opin Infect Dis 23:567–577
Boudewijns M, Verweij PE, Melchers WJ (2006) Molecular diagnosis of invasive aspergillosis: the long and winding road. Future Microbiol 1:283–293
White PL, Perry MD, Moody A, Follett SA, Morgan G, Barnes RA (2011) Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive aspergillosis. J Clin Microbiol 49:2169–2174
Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E, Fuso L, De Pascale G, Bello G, Antonelli M, Fadda G, Posteraro B (2011) Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 49:4273–4278
De Pauw B, Walsh TJ, Donelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Benett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821
Walsh TJ, Wissel MC, Grantham KJ, Petraitiene R, Petraitis V, Kasai M, Francesconi A, Cotton MP, Hughes JE, Greene L, Bacher JD, Manna P, Salomoni M, Kleiboeker SB, Reddy SK (2011) Molecular detection and species-specific identification of medically important Aspergillus species by real-time PCR in experimental invasive pulmonary aspergillosis. J Clin Microbiol 49:4150–4157
Thornton C, Johnson G, Agrawal S (2012) Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp 22:3721
Acknowledgments and funding
This work was partially supported by a grant from Pfizer Inc. (nº. IIR#WS1948668). RA is supported by Fundação para a Ciência e a Tecnologia (FCT) Ciência 2007 and by the European Social Fund. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT.
Conflict of interest
The authors have no financial relationship with the organization that sponsored the research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beirão, F., Araujo, R. State of the art diagnostic of mold diseases: a practical guide for clinicians. Eur J Clin Microbiol Infect Dis 32, 3–9 (2013). https://doi.org/10.1007/s10096-012-1722-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-012-1722-7